SIGA

SIGA Technologies, Inc.

Healthcare · $244M market cap

Verdict

Share price

$3.38

close of Oct 3, 2026

Fair value

$5.56

Sticker Price

Payback Price

$2.22

buy price

Undervalued

SIGA is Undervalued: at $3.38 it trades 39% below its fair value of $5.56. Its buy price (Payback Price) is $2.22, 34% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew -5% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-8.0% a year✗
Equity per share growth15.3% a year✓
Sales growth19.4% a year✓
Free cash flow growth3.9% a year✗
Return on invested capital22.0%✓

Follow SIGA

Get notified when it reaches its buy price of $2.22. Free.

Create a free account

About SIGA Technologies, Inc.

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to…

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

SIGA stock (SIGA Technologies, Inc.): fair value $5.56, Undervalued — PaybackPrice